Anastomosis Devices Market Summary

The global anastomosis devices market was valued at USD 4.19 billion in 2024 and is projected to reach USD 5.80 billion by 2030, growing at a CAGR of 5.6% from 2025 to 2030. An estimated 310 million major surgeries are performed annually, with the U.S. accounting for 40 to 50 million of these operations. As surgical procedures become more common worldwide, the need for reliable, efficient, and safe devices to facilitate the connection of tissues and vessels continues to rise, reinforcing the importance of advanced anastomosis technologies in modern surgical practices.

This escalation is largely propelled by an aging population and increasing cases of lifestyle-related diseases, particularly cardiovascular conditions and cancer. As surgical intervention becomes a standard necessity in addressing these health challenges, the demand for effective anastomosis devices has escalated. These devices play a crucial role in ensuring precise tissue joining, minimizing complications, and improving post-operative recovery. As a result, the market is positioned for steady growth as healthcare systems strive to enhance surgical outcomes and reduce procedural risks.

Key Market Trends & Insights

• The North America region held the largest market share, accounting for 40.2% of the total market revenue in 2024. The region’s strong dominance is supported by advanced healthcare infrastructure, high surgical volumes, and widespread adoption of technologically sophisticated medical devices.
• The Asia Pacific region is identified as the fastest-growing market, with a CAGR of 6.9% over the forecast period. Factors such as rising healthcare investment, expanding access to surgical care, and a growing burden of chronic diseases contribute to this rapid regional growth.
• By product, the disposable products segment contributed to the largest share of around 88.5% of the global market revenue in 2024. Disposable devices are preferred due to their ease of use, reduced risk of cross-contamination, and compliance with stringent infection control standards.
• By application, cardiovascular surgery led the market and accounted for a share of 51.0% in 2024. The high prevalence of heart-related conditions and the increasing number of bypass and vascular procedures support the dominance of this segment.
• By end use, hospitals held the largest revenue share of 57.5% in 2024. Hospitals remain the primary centers for complex surgical interventions, driving consistent demand for advanced anastomosis solutions.

Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 4.19 Billion
• 2030 Projected Market Size: USD 5.80 Billion
• CAGR (2025-2030): 5.6%
• North America: Largest Market in 2024

Key Companies & Market Share Insights

Some key companies operating in the market include Medtronic; MIZUHO Corporation; Getinge; Peters Surgical; and Baxter; among others. Key players operating in the market are focusing on technological innovations and developing advanced technology-based devices to gain a significant revenue share. Companies are focusing on Gripping Surface Technology (GST), magnetic anastomosis technology, and 3D stapling technology for developing anastomosis devices that can reduce leaks at the staple line and provide less invasive solutions for surgeons & patients.

• MIZUHO Corporation specializes in advanced surgical instruments and medical devices tailored for anastomosis procedures. Their portfolio includes specialized clamps and suturing devices that enhance surgical precision and improve patient outcomes during complex cardiovascular surgeries.
• Peters Surgical emphasizes innovative surgical solutions, notably their Enclose® II Proximal Anastomosis Assist Device, designed for anastomosis during beating heart surgeries. Their products enhance efficiency and safety in surgical procedures, providing comprehensive solutions for diverse anastomotic techniques.

Key Players

• Medtronic
• MIZUHO Corporation
• Getinge
• Peters Surgical
• Baxter
• Medical Device Business Services, Inc.
• CarpoNovum AB
• Vascular Graft Solutions Ltd.
• Medline Industries, LP.
• Seger Surgical Solutions Ltd.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global anastomosis devices market is expected to experience steady growth as surgical volumes rise and chronic diseases become increasingly prevalent. With aging populations and lifestyle-related health issues placing greater pressure on healthcare systems, the demand for reliable anastomosis tools will continue to expand. North America’s strong market position, combined with rapid growth across Asia Pacific, reflects broad adoption of advanced surgical technologies. The dominance of disposable products and cardiovascular applications further emphasizes the shift toward safer, more efficient procedures. As hospitals remain key users, ongoing innovation will support improved surgical outcomes, reduced complication rates, and enhanced patient recovery worldwide.